Okuyama N, Rodgers K E, Wang C Y, Girgis W, Oz M, St Amand K, Pines E, DeCherney A H, Rose E A, Cohn D, diZerega G S
Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, 90033, USA.
J Surg Res. 1998 Aug;78(2):118-22. doi: 10.1006/jsre.1998.5317.
The purpose of this study was to test the efficacy of three bioresorbable films of polyethylene glycol (EO) and polylactic acid (LA) (EO/LA = 1.5, 2.5, and 3.0) in the prevention of adhesion formation between the epicardium and the sternum (retrosternal adhesions) in a rabbit model. Retrosternal adhesions were generated by sternotomy, pericardiotomy, and abrasion of the anterior epicardium. The adhesion barrier was placed between the epicardium and the sternum and sutured to the edge of the pericardium. Epicardial adhesions were evaluated 14-20 days later by assessing the area of the epicardium covered by adhesions. In the control rabbits, tenacious adhesions were observed between sternum and the central portion of epicardium (portion exposed through the pericardiotomy) which were difficult to dissect. When a bioresorbable film was placed over the pericardium, adhesion formation at the central strip of the epicardium (area between the sternum and the epicardium exposed through the pericardium) could be reduced or prevented. At this site, the areas of adhesion formation were 0% (EO/LA = 1.5), 8.4 +/- 2.8% (EO/LA = 2.5), and 5.6 +/- 4.7% (EO/LA = 3.0) of the central strip, significantly less than that observed in the control group, 78.0 +/- 5.8% (P < 0.01). At the anterior left and right and posterior apex of the heart (sites where the film was not placed), there were no differences between control and treatment groups. The films were completely resorbed at the time of necropsy in group EO/LA = 2.5 and 3.0. Small pieces of film were observed in group EO/LA = 1.5. In conclusion, the bioresorbable films [EO/LA = 1.5 (REPEL-CV), 2.5, or 3.0] were efficacious in the reduction of retrosternal adhesions to the epicardium.
本研究的目的是在兔模型中测试三种聚乙二醇(EO)和聚乳酸(LA)(EO/LA = 1.5、2.5和3.0)生物可吸收膜预防心外膜与胸骨之间粘连形成(胸骨后粘连)的效果。通过胸骨切开术、心包切开术和心外膜前部擦伤来产生胸骨后粘连。将粘连屏障置于心外膜与胸骨之间,并缝合至心包边缘。14 - 20天后,通过评估粘连覆盖的心外膜面积来评价心外膜粘连情况。在对照兔中,观察到胸骨与心外膜中央部分(通过心包切开术暴露的部分)之间存在紧密粘连,难以分离。当在心包上放置生物可吸收膜时,心外膜中央条带(胸骨与通过心包切开术暴露的心外膜之间的区域)的粘连形成可减少或预防。在此部位,粘连形成面积分别为中央条带的0%(EO/LA = 1.5)、8.4±2.8%(EO/LA = 2.5)和5.6±4.7%(EO/LA = 3.0),显著小于对照组观察到的78.0±5.8%(P < 0.01)。在心脏的左前、右前和后尖部(未放置膜的部位),对照组和治疗组之间没有差异。在EO/LA = 2.5和3.0组中,尸检时膜已完全吸收。在EO/LA = 1.5组中观察到有小块膜。总之,生物可吸收膜[EO/LA = 1.5(REPEL - CV)、2.5或3.0]在减少胸骨后与心外膜的粘连方面是有效的。